Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial-Reference-Cited by-同舟云学术

Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial

Published:2015-07-21 Issue:1 Volume:15 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Andrade-Dávila Víctor Fernando,Chávez-Tostado Mariana,Dávalos-Cobián Carlos,García-Correa Jesús,Montaño-Loza Alejandro,Fuentes-Orozco Clotilde,Macías-Amezcua Michel Dassaejv,García-Rentería Jesús,Rendón-Félix Jorge,Cortés-Lares José Antonio,Ambriz-González Gabriela,Cortés-Flores Ana Olivia,Alvarez-Villaseñor Andrea del Socorro,González-Ojeda Alejandro

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/article/10.1186/s12876-015-0314-2/fulltext.html

Reference38 articles.

1. Freeman ML. Complications of endoscopic retrograde cholangiopancreatography: avoidance and management. Gastrointes Endosc Clin N Am. 2012;22:567–86.

2. Balmadrid B, Kozarek R. Prevention and management of adverse events of endoscopic retrograde cholangiopancreatopgraphy. Gastrointest Esdosc Clin N Am. 2013;23:385–403.

3. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335:909–18.

4. Masci E, Mariani A, Curioni S, Testoni PA. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy. 2003;35:830–4.

5. Dumonceau JM, Andriulli A, Deviere J, Mariani A, Rigaux J, Baron TH, et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy. 2010;42:503–15.

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NSAIDs do not reduce severity among post-ERCP pancreatitis patients;Pancreatology;2024-02

2. Incidence, severity, and mortality of post-ERCP pancreatitis: an updated systematic review and meta-analysis of 145 randomized controlled trials;Gastrointestinal Endoscopy;2023-07

3. Universal prophylactic rectal nonsteroidal anti-inflammatory drugs with a policy of selective pancreatic duct stenting significantly reduce post-endoscopic retrograde cholangiopancreatography pancreatitis;Indian Journal of Gastroenterology;2023-05-10

4. Predictive Value of Different Scoring Systems on the Prognosis of Pancreatitis after Endoscopic Retrograde Cholangiopancreati-tis;Advances in Clinical Medicine;2023

5. Effect of rectal indomethacin on prevention of pancreatitis after ERCP for choledocholithiasis: a prospective randomized clinical trial;Revista Española de Enfermedades Digestivas;2023